Published in Blood Weekly, May 27th, 2010
"The relaxation response to fasudil of GSV taken from diabetic patients was markedly increased but the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.